N-Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM8
Open Access
- 14 September 2021
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 38 (10) , 1-11
Abstract
Although patients with early localized prostate cancer can survive longer, castration-resistant prostate cancer (CRPC) has gradually emerged with the use of androgen deprivation therapy (ADT). N-Myc and TEM8 play a vital role in the progression of several cancer types. However, the underlying mechanism of how N-Myc and TEM8 promote the progression of prostate cancer remains unclear. In this study, the expression of N-Myc and TEM8 was detected in benign prostatic hyperplasia (BPH) and prostate cancer (PCa) tissues by immunohistochemistry (IHC). LNCaP cell lines were maintained in RPMI 1640 medium supplemented with 10% charcoal-stripped fetal bovine serum. Subsequently, R language software was used to verify our results. Tubule formation assay of human umbilical vein endothelial cell (HUVEC) was conducted to examine the effect of N-Myc and TEM8 overexpression on angiogenesis in prostate cancer cells. IHC results showed a positive correlation between the expression of N-Myc and TEM8 in prostate cancer tissues. Further analysis showed that N-Myc and TEM8 were associated with clinicopathological features and poor prognosis in prostate cancer patients. Moreover, the overexpression of N-Myc and TEM8 promoted proliferation of prostate cancer cells and angiogenesis. Additionally, N-Myc and TEM8 overexpression was associated with therapeutic resistance. We further found that N-Myc promoted angiogenesis and therapeutic resistance in prostate cancer via TEM8. Hence, targeting N-Myc/TEM8 pathway in prostate cancer would be a novel therapeutic strategy to enhance the treatment of prostate cancer patients.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81972414)
This publication has 21 references indexed in Scilit:
- Increasing incidence of metastatic prostate cancer in the United States (2004–2013)Prostate Cancer and Prostatic Diseases, 2016
- N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial CellsCancer Cell, 2016
- ANTXR1, a Stem Cell-Enriched Functional Biomarker, Connects Collagen Signaling to Cancer Stem-like Cells and Metastasis in Breast CancerCancer Research, 2013
- Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate CancerNeoplasia, 2013
- TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer TypesCancer Cell, 2012
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug TargetsCancer Discovery, 2011
- Molecular genetics of prostate cancer: new prospects for old challengesGenes & Development, 2010
- Endosomal recycling regulates anthrax toxin receptor 1/tumor endothelial marker 8-dependent cell spreadingExperimental Cell Research, 2010
- Genes Expressed in Human Tumor EndotheliumScience, 2000
- Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.1993